Ironwood Pharma to acquire Swiss-based VectivBio in $1 bln deal
22/05/2023 12:05
May 22 (Reuters) - Ironwood Pharmaceuticals Inc IRWD.O said on Monday it would acquire Switzerland-based drug developer VectivBio Holding AG VECT.O in a deal valued at about $1 billion, including debt. (Reporting by Raghav Mahobe in Bengaluru; Editing by Janane Venkatraman) ((Raghav.Mahobe@thomsonreuters.com;))
Recent news on VectivBio Holding AG
See all newsBrief: Ironwood And VectivBio Announce Expiration Of Hart-Scott-Rodino Waiting Period For Proposed Acquisition Of VectivBio
Brief: Ironwood Pharmaceuticals Says If Deal Aborts, VectivBio To Pay Termination Fee
U.S. STOCKS ON THE MOVE-Pfizer, Zoom Video, American Airlines
U.S. STOCKS ON THE MOVE-Atea Pharma, Microbot Medical, Krystal
U.S. STOCKS ON THE MOVE-NuScale Power Corp, Foot Locker, Greenhill